Daily PrEP With Emtricitabine / Tenofovir Alafenamide Non-Inferior To Emtricitabine / Tenofovir Disoproxil Fumarate, Study Suggests.

March 08, 2019

MedPage Today (3/7, Walker) reports a new study suggests that “daily emtricitabine/tenofovir alafenamide (F/TAF, Descovy) was non-inferior to emtricitabine/tenofovir disoproxil fumarate (F/TDF, Truvada) for pre-exposure prophylaxis (PrEP) in men who have...